INFI
Infinity Pharmaceuticals, Inc.
INFI
INFI
Delisted
INFI was delisted on the 13th of September, 2023.
83 hedge funds and large institutions have $136M invested in Infinity Pharmaceuticals, Inc. in 2021 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 25 increasing their positions, 9 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
7% less call options, than puts
Call options by funds: $1.66M | Put options by funds: $1.78M
Holders
83
Holding in Top 10
–
Calls
$1.66M
Puts
$1.78M
Top Buyers
| 1 | +$21.2M | |
| 2 | +$7.56M | |
| 3 | +$5.33M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.92M |
| 5 |
TLP
Tri Locum Partners
New York
|
+$3.91M |
Top Sellers
| 1 | -$29.2M | |
| 2 | -$6.72M | |
| 3 | -$3.49M | |
| 4 |
BBA
Baker Bros. Advisors
New York
|
-$1.11M |
| 5 |
EI
EAM Investors
Solana Beach,
California
|
-$893K |